Fundz

Atavistik Bio Appoints Bryan Stuart as Chief Executive

PRIVATEJul 17, 2023

Position

Chief Executive Officer

Company

Atavistik Bio

Bryan Stuart
bryanstuart@atavistikbio.com
CambridgeBiotechnologySoftwareHealth CareScience And Engineering

Description

CAMBRIDGE, Mass., July 17, 2023 -- Atavistik Bio, a biotechnology company focused on developing transformative small molecule therapeutics by revolutionizing the discovery and interrogation of new allosteric protein-metabolite interactions with its AMPS platform, today announced the appointment of Bryan Stuart as Chief Executive Officer and a Director on the company’s Board. Mr. Stuart will succeed Jeff Goater, a venture partner at The Column Group, who has served as interim CEO of Atavistik Bio since January 2022 and will continue to serve as a Director on Atavistik Bio’s Board.

Quick answer

Atavistik Bio Appoints Bryan Stuart as Chief Executive (July 17, 2023). Atavistik Bio is based in Cambridge, Massachusetts, United States.

Who is the new Chief Executive Officer at Atavistik Bio?
Atavistik Bio named Bryan Stuart Chief Executive Officer, announced July 17, 2023.
What did Atavistik Bio announce on July 17, 2023?
CAMBRIDGE, Mass., July 17, 2023 -- Atavistik Bio, a biotechnology company focused on developing transformative small molecule therapeutics by revolutionizing the discovery and interrogation of new allosteric protein-metabolite interactions with its AMPS platform, today announced the appointment of Bryan Stuart as Chief Executive Officer and a Director on the company’s Board. Mr. Stuart will succeed Jeff Goater, a...
What does Atavistik Bio do?
Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on oncology.
Where is Atavistik Bio based?
Atavistik Bio is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Koneksa Health (June 27, 2023), Zephyr AI, Inc. (June 5, 2023), Ensem Therapeutics (June 5, 2023) and Triumvira Immunologics Inc. (July 20, 2023) also announced leadership changes within 45 days of Atavistik Bio.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Atavistik Bio, and when

A new leader at Atavistik Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Atavistik Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Atavistik Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Atavistik Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Atavistik Bio

Location

Cambridge, Massachusetts, United States

About

Atavistik Bio is a biotechnology company accelerating the discovery and development of transformative precision allosteric therapeutics to address serious unmet patient needs, with a focus on oncology. Since its inception, Atavistik Bio has rapidly established an emerging pipeline of allosteric therapeutics with the potential to achieve superior efficacy and tolerability profiles by leveraging the power of allostery. ATV-1601, a selective allosteric inhibitor for solid tumors, is anticipated to enter the clinic in early 2025. Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, and Lux Capital.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Atavistik Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Bryan
Likely contact at this company
••••••••@••••••••

See Bryan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Atavistik Bio's next move

Learn about Strategic plan

Atavistik Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.